Journal of Medicinal Chemistry p. 9175 - 9187 (2019)
Update date:2022-08-30
Topics:
Takada, Hiroyuki
Kaieda, Akira
Tawada, Michiko
Nagino, Tomoko
Sasa, Katsunori
Oikawa, Tatsuo
Oki, Akiko
Sameshima, Tomoya
Miyamoto, Kazumasa
Miyamoto, Makoto
Kokubu, Yuko
Tozawa, Ryuichi
Sakurai, Hidetoshi
Saito, Bunnai
Dysferlinopathies, which are muscular diseases caused by mutations in the dysferlin gene, remain serious medical problems due to the lack of therapeutic agents. Herein, we report the design, synthesis, and structure-activity relationships of a 2,6-disubst
View MoreBeijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Suzhou Jingye Medicine & Chemical Co., Ltd
website:http://www.jingyechem.cn
Contact:+86-512-66658588
Address:No. 88, Sanlian Street, Jinfeng Road, Suzhou New District, Jiangsu Province, P. R. China
Tangshan Moneide Trading Co., Ltd.
Contact:+86-315-8309571
Address:2-7-420 Jidong Building Materials Commercial Center, Tangshan, Hebei, 064000 China
Contact:0086 533 2282832
Address:Zibo,Shandong
Lonzeal Pharmaceuticals Co., Ltd.
website:http://www.lonzeal.com
Contact:+86-13381011962
Address:RM 801, Yue MOMA, No. 26 Anningzhuang Rd. Haidian District, Beijing, China
Doi:10.1016/j.molstruc.2016.05.034
(2016)Doi:10.1021/ja00906a048
(1963)Doi:10.1021/ja00239a067
(1987)Doi:10.1016/j.mcat.2021.111440
(2021)Doi:10.1039/c5cc00902b
(2015)Doi:10.1016/j.poly.2015.07.015
(2015)